XML 21 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Millions
Jun. 30, 2018
Dec. 31, 2017
Current Assets:    
Cash and cash equivalents $ 481.2 $ 524.4
Accounts receivable, less allowance for doubtful accounts 1,335.3 1,544.1
Inventories 2,158.5 2,068.3
Prepaid expenses and other current assets 500.2 428.0
Total Current Assets 4,475.2 4,564.8
Property, plant and equipment, net 1,986.9 2,038.6
Goodwill 10,595.9 10,668.4
Intangible assets, net 7,996.6 8,353.4
Other assets 436.2 388.8
Total Assets 25,490.8 26,014.0
Current Liabilities:    
Accounts payable 355.7 330.2
Income taxes payable 211.7 165.2
Other current liabilities 1,186.2 1,349.3
Current portion of long-term debt 100.0 1,225.0
Total Current Liabilities 1,853.6 3,069.7
Deferred income taxes 1,080.9 1,101.5
Long-term income tax payable 755.0 744.0
Other long-term liabilities 343.8 445.8
Long-term debt 9,413.3 8,917.5
Total Liabilities 13,446.6 14,278.5
Commitments and Contingencies (Note 15)
Stockholders' Equity:    
Common stock, $0.01 par value, one billion shares authorized, 307.2 million shares issued in 2018 (306.5 million in 2017) 3.1 3.1
Paid-in capital 8,596.8 8,514.9
Retained earnings 10,327.9 10,022.8
Accumulated other comprehensive loss (163.0) (83.2)
Treasury stock, 103.8 million shares in 2018 (103.9 million shares in 2017) (6,721.7) (6,721.8)
Total Zimmer Biomet Holdings, Inc. stockholders' equity 12,043.1 11,735.8
Noncontrolling interest 1.1 (0.3)
Total Stockholders' Equity 12,044.2 11,735.5
Total Liabilities and Stockholders' Equity $ 25,490.8 $ 26,014.0